Objective: Rhinitis medicamentosa is drug-induced rhinitis which occurs by prolonged and overdose usage of topical nasal decongestants. There is not much of treatment choice rather than nasal steroids. In this pathological study, we have been aimed to represent the healing effects of xylitol on damaged nasal mucosa due to rhinitis medicamentosa.
Method: 30 Wistar rats were separated into 5 groups. During 2 months, oxymetazoline was given to the first group, and saline was given to second group intranasally. First and second group animals were examined at the end of 2 months and rhinitis medicamentosa was detected. Oxymetazoline was given to the third, fourth, and fifth groups during 2 months. Then xylitol solution, mometasone, and saline were applied, respectively, for 15 days. After the experiment, rats' nasal mucosas were evaluated histopathologically.
Results: Xylitol and mometasone were found to be more effective than the control group in terms of histopathological changes. Effectivity of xylitol and mometasone was compared and not a significant value was determined.
Conclusions: According to the results, xylitol solution is effective as mometasone, usable and well-priced in the treatment of rhinitis medicamentosa. More comprehensive and ultrastructural studies on animals and human studies with rhinometric evaluation should be performed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s00405-019-05605-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Improvement of CPAP tolerance and adherence in a patient with obstructive sleep apnea with the use of nasal steroids and nasal oxymetazoline.
J Clin Sleep Med
November 2024
Indiana University School of Medicine, Department of Internal Medicine, Division of General Internal Medicine.
Adherence to positive airway pressure (PAP) therapy is a challenge in patients with allergic rhinitis. We present a case of a 62-year-old male with OSA who had been struggling with PAP therapy for ten years. Intranasal fluticasone alone did not result in tolerance of PAP therapy.
View Article and Find Full Text PDFOutcomes after Functional Nasal Surgery in Patients with Versus without Rhinitis Medicamentosa.
Laryngoscope
October 2024
Department of Otolaryngology-Head and Neck Surgery, Henry Ford Health, Detroit, Michigan, U.S.A.
Objective: Topical nasal decongestants (TNDs) are used to reduce nasal soft tissue edema and obstruction. However, after frequent TND use, patients can develop rhinitis medicamentosa (RM) with rebound nasal edema and obstruction. Management of RM has centered largely on TND cessation ± intranasal corticosteroids.
View Article and Find Full Text PDFRise and fall of decongestants in treating nasal congestion related diseases.
Expert Opin Pharmacother
October 2024
Department of Otorhinolaryngology & Clinical Allergy Center, The First Affiliated Hospital, Nanjing Medical University, Nanjing, China.
Article Synopsis
- Decongestants are medicines that help relieve stuffy noses caused by illnesses like colds and allergies.
- This article reviews research to help doctors use decongestants safely and effectively for their patients.
- It's important to use decongestants carefully and avoid buying products with unknown ingredients, as improper use can cause more problems.
[Not Available].
Ugeskr Laeger
September 2024
Afdeling for Øre-Næse-Halskirurgi og Audiologi, Københavns Universitetshospital - Rigshospitalet.
Article Synopsis
- - Sales of over-the-counter decongestant nasal sprays in Denmark have doubled from 2011 to 2023.
- - Prolonged use of these sprays can lead to risks like rhinitis medicamentosa, a condition that worsens nasal congestion.
- - There is a crucial need for better patient education on safe usage and side effects, along with more research to help health authorities regulate these products effectively.
Pharmacists' Attitudes Towards Long-Term Use of Nasal Decongestants: A Cross-Sectional Study.
J Multidiscip Healthc
March 2024
College of Medicine, Prince Sattam Bin Abdulaziz, Alkharj, Saudi Arabia.
Background: Rhinitis medicamentosa is a nonallergic inflammation of the nasal mucosa caused by topical decongestants overuse. It mainly affects young and middle-aged adults. Therefore, the aim of this study was to investigate the attitudes of pharmacists regarding the utilization of over-the-counter intranasal decongestants.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!